Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Food intake increases liver stiffness measurements and hampers reliable values in patients with chronic hepatitis B and healthy controls: the PROLIFICA experience in The Gambia.
Lemoine M, Shimakawa Y, Njie R, Njai HF, Nayagam S, Khalil M, Goldin R, Ingiliz P, Taal M, Nyan O, Corrah T, D'Alessandro U, Thursz M. Lemoine M, et al. Among authors: nayagam s. Aliment Pharmacol Ther. 2014 Jan;39(2):188-96. doi: 10.1111/apt.12561. Epub 2013 Dec 5. Aliment Pharmacol Ther. 2014. PMID: 24308698 Free article.
PROLIFICA: a story of West African clinical and research collaborations to target hepatitis B-related hepatocellular carcinoma in West Africa.
Howell J, Ladep NG, Nayagam S, Lemoine M, Garside DA, Crossey MME, Okeke E, Njie R, Ka MM, Taal M, Thursz MR, Taylor-Robinson SD. Howell J, et al. Among authors: nayagam s. QJM. 2016 Jun;109(6):373-375. doi: 10.1093/qjmed/hcv118. Epub 2015 Jun 22. QJM. 2016. PMID: 26106184 Free PMC article. No abstract available.
The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, Goldin R, Njai HF, Ndow G, Taal M, Cooke G, D'Alessandro U, Vray M, Mbaye PS, Njie R, Mallet V, Thursz M. Lemoine M, et al. Among authors: nayagam s. Gut. 2016 Aug;65(8):1369-76. doi: 10.1136/gutjnl-2015-309260. Epub 2015 Jun 24. Gut. 2016. PMID: 26109530 Free PMC article.
Prevention of Liver Fibrosis and Cancer in Africa: The PROLIFICA project--a collaborative study of hepatitis B-related liver disease in West Africa.
Howell J, Ladep NG, Lemoine M, Nayagam S, Toure PS, Diop MM, Daveiga Joao Armindo, Sall AS, Lo G, Crossey MM, Thursz MR, Taylor-Robinson SD, Ka MM. Howell J, et al. Among authors: nayagam s. S Afr Med J. 2015 Mar;105(3):185-6. doi: 10.7196/samj.8880. S Afr Med J. 2015. PMID: 26294822 Free article. No abstract available.
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.
Lemoine M, Shimakawa Y, Njie R, Taal M, Ndow G, Chemin I, Ghosh S, Njai HF, Jeng A, Sow A, Toure-Kane C, Mboup S, Suso P, Tamba S, Jatta A, Sarr L, Kambi A, Stanger W, Nayagam S, Howell J, Mpabanzi L, Nyan O, Corrah T, Whittle H, Taylor-Robinson SD, D'Alessandro U, Mendy M, Thursz MR; PROLIFICA investigators. Lemoine M, et al. Among authors: nayagam s. Lancet Glob Health. 2016 Aug;4(8):e559-67. doi: 10.1016/S2214-109X(16)30130-9. Lancet Glob Health. 2016. PMID: 27443781 Free article. Clinical Trial.
Requirements for global elimination of hepatitis B: a modelling study.
Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D, Hallett TB. Nayagam S, et al. Lancet Infect Dis. 2016 Dec;16(12):1399-1408. doi: 10.1016/S1473-3099(16)30204-3. Epub 2016 Sep 13. Lancet Infect Dis. 2016. PMID: 27638356 Free article.
114 results